CN104388584A - Rift Valley fever virus nucleic acid molecule characteristic standard sample and preparation method thereof - Google Patents

Rift Valley fever virus nucleic acid molecule characteristic standard sample and preparation method thereof Download PDF

Info

Publication number
CN104388584A
CN104388584A CN201410597296.XA CN201410597296A CN104388584A CN 104388584 A CN104388584 A CN 104388584A CN 201410597296 A CN201410597296 A CN 201410597296A CN 104388584 A CN104388584 A CN 104388584A
Authority
CN
China
Prior art keywords
sequence
plasmid
standard sample
preparation
fever virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410597296.XA
Other languages
Chinese (zh)
Inventor
薛芳
李云峰
孙时
冯晓明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410597296.XA priority Critical patent/CN104388584A/en
Publication of CN104388584A publication Critical patent/CN104388584A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/166Oligonucleotides used as internal standards, controls or normalisation probes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention discloses a preparation method of a Rift Valley fever virus nucleic acid molecule characteristic standard sample, which comprises the following steps: synthesizing the sequence, cloning the vector, connecting the target segment and vector, converting the plasmid, extracting the recombinant plasmid, freeze-drying, preserving and the like to obtain the Rift Valley fever virus nucleic acid molecule characteristic standard sample. The standard sample prepared by the invention comprises virus characteristic sequence information and is suitable for the virus and content level in the analytical sample. The standard sample disclosed by the invention has the advantages of favorable uniformity, high stability and high purity, and can be stored for a long time. The preparation method is simple in process, can provide a standard sample for Rift Valley fever virus detection research, medical research and the like to implement comparison among different laboratory results, thereby ensuring the quality control on the laboratory. The preparation method provides a standard sample for quick accurate detection on Rift Valley fever virus by quarantine inspection mechanisms, import and export trade and other enterprises.

Description

Rift Valley fever virus nucleic acid molecule characteristic standard sample and preparation method thereof
Technical field
The present invention relates to a kind of Rift Valley fever virus nucleic acid molecule characteristic standard sample and preparation method thereof, belong to biology field.
Background technology
Rift Valley fever virus (Rift Valley fever virus, RVFV) belongs to family Bunyaviridae phlebotomus fever virus and belongs to, and mosquito is primary vehicle.This virus can cause the acute hemorrhagic infectious diseases common to human beings and animals with high incidence and high case fatality rate.After human infection's Rift Valley fever, main manifestations is heating, weak, headache, myalgia, and arthrodynia, has nauseating sometimes, vomiting, and part there will be eye disease, meningitis or hemorrhagic fever.Nearly more than 10 years, this disease was comparatively serious at Africa, and 2006-2007 Kenya reports 684 examples (155 examples are dead) altogether, and Somalia reports 114 examples (51 examples are dead); Within 2007, Tanzania reports 290 examples (117 examples are dead), the Sudan's report 228 example; Within 2008,418 examples (7 examples are dead) (WHO, 2007,2008) are reported in Madagascar.This disease was once considered to only at Africa, until in September, 2000 Saudi Arabia and Yemen have confirmed cases, this disease to have to Asia trend that other areas and Europe are propagated.China's area is vast, geographical conditions complexity is various, extend across cold, warm, hot three bands, there is various kinds of media insect, suitable multiple arboviruses existence, China possesses that Rift Valley fever virus grows, the induced conditions of the natural condition propagated and epidemic outbreak, and, along with foreign trade increases severely, China's reply Rift Valley fever virus causes shows great attention to.
At present, the diagnostic method of Rift Valley fever virus is primarily of diagnostic techniquess such as virus purification, agarose immunodiffusion technique, molecular biology.In recent years, along with the development of Protocols in Molecular Biology, the advantage that real-time fluorescence PCR technology is quick with it, responsive, specificity is good accounts for very large advantage, cause the concern of numerous investigator, but existing molecular Biological Detection test kit mostly is company and designs positive control according to document, does not have unified standard.Along with the increase of foreign trade, the inspection process time limit shortens, and is difficult to the quality control ensureing laboratory.
Summary of the invention
For the problems referred to above, the present invention develops a kind of Rift Valley fever virus nucleic acid molecule characteristic standard sample, can be used for positive control when characteristic sequence detects, to ensure the tractability of detected result.Concrete technical scheme is as follows.
The preparation method of Rift Valley fever virus nucleic acid molecule characteristic standard sample of the present invention, mainly comprises the steps:
1) synthesize virus sequence, its sequence is as described in Sequence NO.1: and a T7 promotor is increased before every section of sequence;
2) composition sequence flush end be cloned into plasmid and cut qualification and glue purification by enzyme;
3) ligation of object fragment and carrier;
4) by competence Bacterial Transformation plasmid;
5) recombinant plasmid extracts; ;
6) spectrophotometer method is adopted to carry out quality examination to recombinant plasmid;
7) choose purity and all qualified recombinant plasmid of integrity, mixed by solution, and again measure concentration and purity, then pipe carries out packing freeze-drying, and the standard model prepared is placed in-80 DEG C of Refrigerator stores.
The qualification of recombinant plasmid is also comprised: namely from the bacterium liquid that step 4) obtains, get 1-3 bacterium colony in step described in the preparation method of above-mentioned Rift Valley fever virus nucleic acid molecule characteristic standard sample, be inoculated in the LB substratum containing ammonia benzyl and cultivate, extract plasmid, then pcr amplification is carried out, PCR primer carries out agarose gel electrophoresis, screening positive clone.
Determining nucleic acid sequence and sequence comparative analysis is also comprised: the bacterium being about to be accredited as through PCR positive recombinant plasmid is checked order and carries out homology analysis in step described in the preparation method of above-mentioned Rift Valley fever virus nucleic acid molecule characteristic standard sample.
The Rift Valley fever virus nucleic acid molecule characteristic standard sample that the present invention obtains, is the recombinant vectors of the nucleotide sequence containing Sequence NO.1.And described recombinant vectors is plasmid.
Further, above-mentioned steps 2) concrete steps of described clone and glue purification are: sequence flush end are cloned in pUC19 plasmid; Enzyme is cut qualification and is selected ecor I and xbai carries out enzyme as the cloning site of plasmid vector and cuts, 37 DEG C, reaction 1-2h, and reaction system is DNA 16 μ L, 10X buffer 2 μ L, ecorI 1 μ L, xbai 1 μ L; Digestion products, through 1% agarose gel electrophoresis, cuts required fragment, and glue reclaims purifying.
Further, above-mentioned steps 3) the ligation concrete steps of described object fragment and carrier are: condition is 16 DEG C, reaction 16h, reaction system is: step 2) the purified product 1 μ L that obtains, composition sequence X μ L: the mol ratio of itself and carrier is 3 ~ 20:1, T4 Ligase 1 μ L, 10X Ligase solution 1 μ L, adds deionized water polishing to 10 μ L.
Further, above-mentioned steps 4) concrete steps of described competence Bacterial Transformation plasmid are: competence bacterium are added in the aseptic Eppendorf pipe of precooling, get the ligation liquid that step 3) obtains, be added in the pipe containing DH5 α competence bacterium, light mixing, leaves standstill 30min, 42 DEG C of heat shock 90s on ice, do not rock pipe, leave standstill 5min on ice, add not containing the LB substratum of ammonia benzyl, 37 DEG C, 225rpm, cultivates 1h and obtains conversion fluid; Get on LB solid medium that conversion fluid coats containing ammonia benzyl, be inverted for 37 DEG C and cultivate 16h.
The present invention is based on the RNA sequence of virus and the basis of cDNA sequence complementation, DNA synthetic technology is utilized to synthesize the nucleic acids characteristic sequence of virus, be cloned in plasmid vector, prepared a kind of standard model comprising virus characteristic sequence information, be suitable for this virus and contents level in analytic sample; Standard model good uniformity provided by the invention, stability is strong, can preserve for a long time, purity is good, and preparation method's process is simple, standard model can be provided for Rift Valley fever virus detect delay, medical research etc., to realize the result comparison of different experiments room, thus ensure the quality control in laboratory; Simultaneously also for the enterprises such as inspection and quarantine mechanism, foreign trade realize providing standard model to the quick and precisely detection of Rift Valley fever virus.
Accompanying drawing explanation
Fig. 1 plasmid enzyme restriction electrophorogram, Fig. 2 recombinant plasmid sequencer map, Fig. 3 sequence alignment is reported, Fig. 4 recombinant plasmid electrophorogram;
Fig. 5 plasmid-20 DEG C deposits rear electrophoresis figure, and Fig. 6 plasmid 0 DEG C deposits rear electrophoresis figure, and Fig. 7 plasmid 4 DEG C deposits rear electrophoresis figure, and Fig. 8 plasmid 20 DEG C deposits rear electrophoresis figure, and Fig. 9 plasmid 37 DEG C deposits rear electrophoresis figure;
Figure 10 group 401-409 in January electrophorogram, Figure 11 group 410-418 in March electrophorogram, Figure 12 group 419-427 in June electrophorogram, Figure 13 group 428-435 in September electrophorogram, Figure 14 group 436-444 in December electrophorogram.
Embodiment
Experiment material: pUC19 plasmid, agarose, restriction enzyme ecor I and xbai, T4 Ligase test kit, gel purification kit, DH5 α bacterial strain, LB substratum are purchased from the precious biotechnology company limited in Dalian, and Wizard PlusSV Minipreps DNA Purification System is purchased from promega company.
Embodiment 1: the preparation of standard model
1. composition sequence: utilize software Clone Manager 7.0 to download from GenBank the sequence published, carry out homology analysis and primer coupling, analyze the virus sequence determining to fit to: CCC CAA TAA AGT GAA AAT TCC TGA GAC ACA TG GCA TCA GGG CTC GGA AGC AAT GTA AGG GGC CTG TGT GGA CTT GTG CAA CAT CAG ATG ATG CAA GGA AGT GGA ACC AAG GCC ATT TTG TTA CAA AGT TTG CCC TCA TGC TAT GTG AGT TCA CCT CTC CCA AAT GGT GGC CAC TGA TCA TTA GGG GAT GTT CAA TGT TTA, sequent synthesis authorized company completes, for ease of nucleic acid sequence in-vitro transcription is become RNA, before every section of sequence, increase a T7 promotor, T7 promoter sequence 20bp:TAA TAC GAC TCA CTA TAG GG,
2. composition sequence flush end be cloned into pUC19 plasmid and cut qualification and glue purification by enzyme: sequence clone being entered in pUC19 plasmid, analyzing through sequence restriction enzyme site, selecting ecor I and xbai carries out enzyme as the cloning site of plasmid vector and cuts, as shown in Figure 1,37 DEG C, reaction 1-2h, reaction system is as follows:
Digestion products, through 1% agarose gel electrophoresis, cuts required fragment, carries out glue reclaim purifying according to Takara company gel purification kit specification sheets;
3. the ligation of object fragment and carrier
Carry out ligation after glue purification, 16 DEG C, reaction 16h, system is as follows:
4. the preparation of competence bacterium
The frozen DH5 α bacterium of picking is inoculated in LB culture medium flat plate, be inverted overnight incubation for 37 DEG C, choose single colony inoculation to spend the night in 37 DEG C of 250rpm shaking culture in 5mL LB substratum, switching 1mL overnight culture enters in 100mL LB liquid nutrient medium cultivates 2-3h in 37 DEG C, makes it to enter logarithmic phase OD 600be about 0.3,4 DEG C, the centrifugal 10min of 4,000g, reclaim bacterium, remove most substratum, add 1 × TSS Buffer of 10mL precooling, resuspended bacterium, be distributed into 200 μ L/ and manage, be placed in-70 DEG C for subsequent use;
5. by competence Bacterial Transformation plasmid: DH5 α competent cell takes out from-70 DEG C of refrigerators, is placed in thawed on ice, gets 100 μ L and is added in the aseptic 1.5mL Eppendorf pipe of precooling.Get the above-mentioned ligation liquid of 10 μ L, be added in the pipe containing DH5 α competence bacterium, gently mix, leave standstill 30min on ice.42 DEG C of heat shock 90s, do not rock pipe.Leave standstill 5min on ice, add 0.9mL not containing the LB substratum of ammonia benzyl, 37 DEG C, 225rpm, cultivate 1h.Get on LB solid medium that 100-300 μ L conversion fluid coats containing ammonia benzyl (100 μ g/mL), be inverted for 37 DEG C and cultivate 16h;
6. the qualification of recombinant plasmid
Get 1-3 bacterium colony, be inoculated in 5mL containing ammonia benzyl LB substratum in, 37 DEG C, 225rpm, cultivate 12h, extract plasmid, and with for template, carry out pcr amplification with universal primer M13, PCR primer carries out agarose gel electrophoresis, screening positive clone;
7. determining nucleic acid sequence and sequence alignment analysis
The bacterium being accredited as positive recombinant plasmid through PCR send Takara company to check order, as shown in Figure 2; Sequencing result Clone Manager 7.0 software carries out sequence homology analysis qualification, and as shown in Figure 3, consistence is 100%;
8. the extraction of recombinant plasmid
Adopt Wizard PlusSV Minipreps DNA Purification System, the bacterium liquid getting 1-10mL incubated overnight moves in 10mL centrifuge tube, the centrifugal 15min of 3,000g, abandons supernatant, being inverted on filter paper makes raffinate stream clean, add the resuspended solution of 250 μ L cell in the bacterial sediment collected gently to mix, complete resuspended bacterium, moves to 1.5mL Eppendorf and manages by re-suspension liquid, add 250 μ L cell pyrolysis liquids more in the tube, mixing 4-6 time of turning upside down; Add 10 μ L alkaline phosphatase enzyme solution, mixing 4-6 time of turning upside down, room temperature leaves standstill 5min; Add 350 μ L neutralizers, mixing 4-6 time of turning upside down, the centrifugal 10min of room temperature 12,000g; Centrifugal column puts into collection tube, centrifugal supernatant is transferred in centrifugal column, room temperature 12, the centrifugal 1min of 000g, discards centrifugal rear liquid, is reentered into by centrifugal column in collection tube, the washing lotion that 750 μ L have added ethanol is added centrifugal column, the centrifugal 1min of room temperature 12,000g, discards centrifugal rear liquid, add 250 μ L washing lotions and repeat above-mentioned steps, the centrifugal 2min of room temperature 12,000g, is transferred in the Eppendorf pipe of an aseptic 1.5ml by centrifugal column, add the rnase-free deionized water of 20-30 μ L sterilizing, place 2-3min, the centrifugal 1min of room temperature 12,000g; Discard centrifugal column, reclaim the plasmid DNA of purifying, the agarose gel electrophoresis purification Identification effect of 1% ,-20 DEG C of preservations;
9. quality examination
Adopt the absorbancy of spectrophotometer method test dna under 260 nm and 280 nm, to evaluate the quality of DNA.The content that the results are shown in Table 1, DNA recombinant plasmid is 2.029 μ g, and replicate measurement error is less than 1%, and sample standard deviation is at <15%, and purity meets the requirements;
Table 1 recombinant plasmid content and purity testing result (mass unit: μ g)
Randomly draw 9 bottles of electrophoresis observation plasmid electrophoresis Tapes types, the results are shown in Figure 4, be respectively Marker from left to right, recombinant plasmid Tapes type all without band of significantly mixing, points out its integrity better;
10. sample packing
Choose purity and all qualified recombinant plasmid of integrity, solution is mixed, measure concentration and purity again, adjustment strength of solution is worth 10.00 μ g/mL, packing freeze-drying (condition: sample is positioned over pre-freeze 24h in-20 DEG C of refrigerators is carried out by 2 μ g/ pipes, ensure that sample is thoroughly freezing, after pre-freeze is terminated, fast sample is placed in the sample tray of Freeze Drying Equipment (SIM company FD5508 type), keep vacuum tightness between 30 ~ 40mtorr, vacuum-drying 24h, is prepared into lyophilized powder sample.), the standard model prepared is placed in-80 DEG C of Refrigerator stores.
Embodiment 2: the uniformity testing of standard model
Randomly draw sample according to random sampling and carry out analysis of Uniformity:
1. homogeneity bottle
Randomly draw 1 bottle, after adding 200 μ L deionized waters, get three parts, every part of 50 μ L, are numbered 101-103, survey three times, the results are shown in Table 2 for every part; The sample standard of appraisal deviation (STDEV)=0.001 of quality, the sample standard of appraisal deviation (STDEV)=0.002 of purity, three groups of quality and purity data are done variance analysis, and quality and purity, without significant difference, meet uniformity requirement,
Homogeneity test result (mass unit: μ g) in table 2 bottle
2. homogeneity bottle
Extract 20 bottles by simple random sampling method, numbering 201-220, survey 3 times for every bottle.Measuring sequence: for the first time, 201 → 220; For the second time, 220 → 201; For the third time, odd number 201 → 219 → even number 202 → 220, the results are shown in Table 3;
The sample standard of appraisal deviation (STDEV)=0.005 of quality, the sample standard of appraisal deviation (STDEV)=0.331 of purity.20 groups of quality and purity data are done variance analysis, and variance is neat, P>0.05, and content and purity, without significant difference, meet uniformity requirement;
Homogeneity test result (mass unit: μ g) between table 3 bottle
Embodiment 3: the stability test of standard model
Randomly draw sample according to random sampling and carry out stability analysis:
1. short-term stability
Randomly draw freeze-drying sample respectively at-20 DEG C, 0 DEG C, 4 DEG C, 25 DEG C, under 37 DEG C of conditions, place 2 weeks (20110314-20110328).Place 8 bottles at each temperature, totally 40 bottles, totally 40 bottles, number from 301-350, survey 3 inferior qualities and purity, and carry out electrophoresis observation integrity for every bottle.With reference to GB/T 15000.3-2008 to the statistical study requirement of sample stability, SPSS 20.0 software is adopted to carry out variance analysis to data, inspection level p<0.05 is for there being notable difference;
5 groups of data (table 4) are done homogeneity test of variance, p<0.05, obvious significant difference is had between group, compare between each group further, no difference of science of statistics between-20 DEG C, 0 DEG C and 4 DEG C of groups, no difference of science of statistics between 25 DEG C and 37 DEG C, and-20 DEG C, 0 DEG C with 4 DEG C three groups with 25 DEG C, 37 DEG C two groups phase mutual significant differences, pass through electrophoresis observation, plasmid band more complete (Fig. 5-7) is organized for-20 DEG C, 0 DEG C with 4 DEG C, and 25 DEG C and 37 DEG C group plasmid band have disappearance (Fig. 8-9), temp. indicator preserve below 4 DEG C 2 weeks comparatively stable, more than 25 DEG C, plasmid has degraded.2 weeks sample quality standard of appraisal deviations (STDEV)=0.004 are placed at-20 DEG C;
Table 4 short-term stability detected result (mass unit: μ g)
Quality statistics
2. permanent stability
Randomly draw a collection of 45 bottles be first placed on-80 DEG C at (20110512), according to the timed interval take out under-20 DEG C of conditions place 12,9,6,3,1 month.9 bottles are placed under each time point.Adopt Synchronos method to measure concentration and purity, and carry out electrophoresis observation integrity.With reference to GB/T 15000.3-2008 to the statistical study requirement of sample stability, SPSS 20.0 software is adopted to carry out variance analysis, inspection level p<0.05 is for there being notable difference.
5 groups of data (table 5) are done homogeneity test of variance, p>0.05, without significant difference between group, meets permanent stability requirement.By 5 groups of its integrities of plasmid electrophoresis detection, as can be seen from Figure, January, March and June group (Figure 10-12) band Tapes type complete, the plasmid organized in September and group in December (Figure 13-14) has and occurs that individually Article 2 band dies down, but basic Tapes type is complete, meets permanent stability requirement.1 year sample quality standard of appraisal deviation (STDEV)=0.108 is placed at-20 DEG C.
Table 5 permanent stability experimental result (mass unit: μ g)
Continued 5
Embodiment 4: the definite value of standard model
1. cooperate definite value
The work of standard model definite value has been participated in jointly by 7 laboratories.Ultraviolet spectrophotometry is adopted to carry out cooperation definite value.Provide 1 bottle of sample for every, point measurement in three days, measures 1 every day, amounts to 3 times.Value data is in table 6, and laboratory averaged measurements is in table 7.
Table 6 laboratory measurements table look-up (mass unit: μ g)
Table 7 laboratory average measurements
2. different methods definite value
Select ultraviolet spectrophotometry and red, orange, green, blue, yellow (ROGBY) to measure, result (table 8) does homogeneity test of variance, p>0.05, points out two kinds of methods consistent to the detected result of sample quality,
Table 8 different methods definite value result (mass unit: μ g)
3. uncertainty combination
The component of uncertainty comprises ununiformity error u1+ stability error between bottle (-20 DEG C/1 year) u2+ replicate measurement error u3, cooperation definite value error u4.Overall uncertainty equals the evolution of each partial uncertainty sum of squares.
The partial uncertainty source of standard model is in table 9.Composite Seismogram is in table 10
As calculated, expanded uncertainty U=0.302 μ g, k=2.
The uncertain component value of table 9
Table 10 Composite Seismogram
Replicate measurement error Cooperation definite value error Composite Seismogram
0.101 0.031 0.1511
Definite value: 2.029 μ g, expanded uncertainty U=0.302 μ g, k=2.
Definite value result shows: the reagent that 1, preparation adopts meets requirement; 2, blending process is reasonable; 3, testing method meets the demands.
The above; be only the present invention's preferably embodiment; but protection scope of the present invention is not limited thereto; anyly be familiar with those skilled in the art in the technical scope that the present invention discloses; be equal to according to technical scheme of the present invention and inventive concept thereof and replace or change, all should be encompassed within protection scope of the present invention.
SEQUENCE LISTING
 
<110> Xue Fang
 
<120> Rift Valley fever virus nucleic acid molecule characteristic standard sample and preparation method thereof
 
<130> 2014
 
<160> 2
 
<170> PatentIn version 3.3
 
<210> 1
<211> 200
<212> DNA
<213> Sequence NO.1
 
<400> 1
ccccaataaa gtgaaaattc ctgagacaca tggcatcagg gctcggaagc aatgtaaggg 60
 
gcctgtgtgg acttgtgcaa catcagatga tgcaaggaag tggaaccaag gccattttgt 120
 
tacaaagttt gccctcatgc tatgtgagtt cacctctccc aaatggtggc cactgatcat 180
 
taggggatgt tcaatgttta 200
 
 
<210> 2
<211> 20
<212> DNA
<213> T7
 
<400> 2
taatacgact cactataggg 20

Claims (8)

1. the preparation method of Rift Valley fever virus nucleic acid molecule characteristic standard sample, is characterized in that, comprise the steps:
1) synthesize virus sequence, its sequence is as described in Sequence NO.1: and a T7 promotor is increased before every section of sequence;
2) composition sequence flush end be cloned into plasmid and cut qualification and glue purification by enzyme;
3) ligation of object fragment and carrier;
4) by competence Bacterial Transformation plasmid;
5) recombinant plasmid extracts;
6) spectrophotometer method is adopted to carry out quality examination to recombinant plasmid;
7) choose purity and all qualified recombinant plasmid of integrity, solution is mixed, and again measure concentration and purity, then carry out packing freeze-drying, the standard model prepared is placed in-80 DEG C of Refrigerator stores.
2. the preparation method of Rift Valley fever virus nucleic acid molecule characteristic standard sample according to claim 1, it is characterized in that, described step also comprises the qualification of recombinant plasmid: from the bacterium liquid that step 4) obtains, get 1-3 bacterium colony, be inoculated in the LB substratum containing ammonia benzyl and cultivate, extract plasmid, carry out pcr amplification, PCR primer carries out agarose gel electrophoresis, screening positive clone.
3. the preparation method of Rift Valley fever virus nucleic acid molecule characteristic standard sample according to claim 2, it is characterized in that, described step also comprises determining nucleic acid sequence and sequence comparative analysis: checked order by the bacterium being accredited as positive recombinant plasmid through PCR and carry out homology analysis.
4. the Rift Valley fever virus nucleic acid molecule characteristic standard sample prepared by method described in claim 1, the recombinant vectors of the nucleotide sequence namely containing Sequence NO.1.
5. Rift Valley fever virus nucleic acid molecule characteristic standard sample according to claim 4, it is characterized in that, described recombinant vectors is plasmid.
6. the preparation method of standard model according to claim 1, is characterized in that, step 2) concrete steps of described clone and purifying are: sequence flush end are cloned in pUC19 plasmid; Enzyme is cut qualification and is selected ecor I and xbai carries out enzyme as the cloning site of plasmid vector and cuts, 37 DEG C, reaction 1-2h, and reaction system is DNA 16uL, 10X buffer 2uL, ecor I 1uL, xbai 1uL; Digestion products, through 1% agarose gel electrophoresis, cuts required fragment, and glue reclaims purifying.
7. the preparation method of standard model according to claim 1, it is characterized in that, described in step 3), the ligation concrete steps of object fragment and carrier are: condition is 16 DEG C, reaction 16h, reaction system is: step 2) purified product 1 uL that obtains, composition sequence X uL: the mol ratio of itself and carrier is 3 ~ 20:1, T4 Ligase 1uL, 10X Ligase solution 1uL, adds deionized water polishing to 10uL.
8. the preparation method of standard model according to claim 1, is characterized in that, described in step 4), the concrete steps of competence Bacterial Transformation plasmid are: be added to by competence bacterium in the aseptic Eppendorf pipe of precooling, get the ligation liquid that step 3) obtains, be added in the pipe containing DH5 α competence bacterium, gently mix, leave standstill 30min on ice, 42 DEG C of heat shock 90s, do not rock pipe, leave standstill 5min on ice, add not containing the LB substratum of ammonia benzyl, 37 DEG C, 225rpm, cultivates 1h and obtains conversion fluid; Get on LB solid medium that conversion fluid coats containing ammonia benzyl, be inverted for 37 DEG C and cultivate 16h.
CN201410597296.XA 2014-10-30 2014-10-30 Rift Valley fever virus nucleic acid molecule characteristic standard sample and preparation method thereof Pending CN104388584A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410597296.XA CN104388584A (en) 2014-10-30 2014-10-30 Rift Valley fever virus nucleic acid molecule characteristic standard sample and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410597296.XA CN104388584A (en) 2014-10-30 2014-10-30 Rift Valley fever virus nucleic acid molecule characteristic standard sample and preparation method thereof

Publications (1)

Publication Number Publication Date
CN104388584A true CN104388584A (en) 2015-03-04

Family

ID=52606540

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410597296.XA Pending CN104388584A (en) 2014-10-30 2014-10-30 Rift Valley fever virus nucleic acid molecule characteristic standard sample and preparation method thereof

Country Status (1)

Country Link
CN (1) CN104388584A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105738624A (en) * 2015-12-28 2016-07-06 中华人民共和国上海出入境检验检疫局 Indirect immuno-fluorescence detection method of rift valley fever virus IgG antibody
CN113061660A (en) * 2020-12-25 2021-07-02 暨南大学 Standard plasmid for identifying mandarin fish species and application thereof
CN114369611A (en) * 2021-12-31 2022-04-19 暨南大学 Standard plasmid molecule for identifying species of pomfret and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102140528B (en) * 2010-12-24 2013-01-16 中国检验检疫科学研究院 New fluorescence quantitative polymerase chain reaction (PCR) detection method for rift valley fever virus and rift valley fever virus detection PCR system
CN102433392B (en) * 2011-12-13 2013-05-15 中国检验检疫科学研究院 Primers and probe for detecting fragment S of rift valley fever virus
CN103952494A (en) * 2014-03-06 2014-07-30 中国动物卫生与流行病学中心 Rift valley fever virus RT-LAMP (reverse transcription-loop-mediated isothermal amplification) detection method

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102140528B (en) * 2010-12-24 2013-01-16 中国检验检疫科学研究院 New fluorescence quantitative polymerase chain reaction (PCR) detection method for rift valley fever virus and rift valley fever virus detection PCR system
CN102433392B (en) * 2011-12-13 2013-05-15 中国检验检疫科学研究院 Primers and probe for detecting fragment S of rift valley fever virus
CN103952494A (en) * 2014-03-06 2014-07-30 中国动物卫生与流行病学中心 Rift valley fever virus RT-LAMP (reverse transcription-loop-mediated isothermal amplification) detection method

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BRIAN H.BIRD ET AL: "Highly Sensitive and Broadly Reactive Quantitative Reverse Transcription-PCR Assay for High-Throughput Detection of Rift Valley Fever Virus", 《JOURNAL OF CLINICAL MICROBIOLOGY》, vol. 45, no. 11, 30 November 2007 (2007-11-30), pages 3506 - 3513 *
WILLIAM C.WILSON ET AL: "Development of a Rift Valley fever real-timeRT-PCR assay that can detect all three genome segments", 《JOURNAL OF VIROLOGICAL METHODS》, vol. 193, 11 July 2013 (2013-07-11), pages 426 - 431 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105738624A (en) * 2015-12-28 2016-07-06 中华人民共和国上海出入境检验检疫局 Indirect immuno-fluorescence detection method of rift valley fever virus IgG antibody
CN105738624B (en) * 2015-12-28 2018-07-10 中华人民共和国上海出入境检验检疫局 A kind of indirect immunofluorescene assay method of Rift Valley fever virus IgG antibody
CN113061660A (en) * 2020-12-25 2021-07-02 暨南大学 Standard plasmid for identifying mandarin fish species and application thereof
CN114369611A (en) * 2021-12-31 2022-04-19 暨南大学 Standard plasmid molecule for identifying species of pomfret and application thereof

Similar Documents

Publication Publication Date Title
Hill et al. Measurement of ice nucleation-active bacteria on plants and in precipitation by quantitative PCR
Grimont et al. Molecular typing of Brucella with cloned DNA probes
CN103421906B (en) Composition and method for detecting drug resistance of staphylococcus aureus
CN114075607B (en) On-site visualization kit for detecting listeria monocytogenes based on SHERLOCK and application
CN109680079A (en) Detect RPA primer, probe, kit and the method for vibrio parahemolyticus
CN111518821A (en) Mycoplasma bovis growth essential protein CDNPase under cell co-culture
CN104388584A (en) Rift Valley fever virus nucleic acid molecule characteristic standard sample and preparation method thereof
CN105200153A (en) Gene probe for simultaneously detecting five food-borne pathogenic bacteria through liquid chip and detection method
CN102094080B (en) Quick molecular detection method for simultaneously detecting three kinds of fusarium toxins and application thereof
CN103184286B (en) Identification method of rice bacterial leaf blight resistance
CN104357581B (en) Ebola virus nucleic acid molecules characteristic standard sample and preparation method thereof
CN107541567B (en) LAMP primer combination for detecting 8 environmental pathogens of cow mastitis and application thereof
Pedro et al. Polymerase chain reaction (PCR) detection of the predominant microcystin-producing genotype of cyanobacteria in Mozambican lakes
CN104404167A (en) Chikungunya virus nucleic acid molecule characteristic standard sample and its preparation method
CN102242114B (en) Method for extracting total DNA from soy and application thereof
CN105331688B (en) The five weight PCR detection methods and its detection kit of pathogenic bacteria in a kind of detection fresh and live agricultural product
CN112176080A (en) Nested PCR primer group, kit and detection method for specifically detecting purple sisal leaf roll disease phytoplasma
Espinoza-Medina et al. PCR identification of Salmonella: potential contamination sources from production and postharvest handling of cantaloupes
CN104726595B (en) The multiple PCR detection kit and its primer special and multi-PCR detection method of three kinds of bacillary seed-borne diseases
CN104404168A (en) Crimean-Congo hemorrhagic fever virus nucleic acid molecule characteristic standard sample and its preparation method
CA2285633C (en) Bacterial plasmids
CN107723348B (en) NASBA detection method for identifying Listeria monocytogenes 1/2c serotype
WO1996019585A1 (en) Typing of microorganisms
CN104388586A (en) Dengue hemorrhagic fever virus I nucleic acid molecular characteristic standard sample and preparation method thereof
AU2020103778A4 (en) Primer Set for Detection of Streptococcus agalactiae, Detection Kit and Multiplex PCR Detection Method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20150304

RJ01 Rejection of invention patent application after publication